Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Cytomx Therapeutics, Inc. shareholders
As of Jun 30, 2026, 170 institutions reported holding Cytomx Therapeutics, Inc., 97.9% of its shares. Largest: Fidelity, Kynam Capital Management, LP and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cytomx Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 32.7M | 15.0% | +759K | Aug 13, 2026 |
| Kynam Capital Management, LP | 21.7M | 10.0% | +6.69M | Aug 14, 2026 |
| BlackRock | 17.6M | 8.1% | +12.3M | Aug 7, 2026 |
| Bank of America | 15.1M | 6.9% | +4.88M | Aug 14, 2026 |
| Vanguard | 11.8M | 5.4% | +913K | Aug 13, 2026 |
| State Street | 11.7M | 5.4% | +6.08M | Aug 7, 2026 |
| Perceptive Advisors LLC | 10.4M | 4.8% | +340K | Aug 14, 2026 |
| Point72 Asset Management, L.P. | 7.81M | 3.6% | −64,357 | Aug 14, 2026 |
| Wellington | 5.17M | 2.4% | +1.59M | Aug 14, 2026 |
| Venrock Adviser, LLC | 4.98M | 2.3% | −5M | Aug 14, 2026 |